These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33278940)

  • 1. Beta-d-glucan-based drug delivery system and its potential application in targeting tumor associated macrophages.
    Su Y; Chen L; Yang F; Cheung PCK
    Carbohydr Polym; 2021 Feb; 253():117258. PubMed ID: 33278940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles.
    Zhang M; Kim JA; Huang AY
    Front Immunol; 2018; 9():341. PubMed ID: 29535722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Glucan-A promising immunocyte-targeting drug delivery vehicle: Superiority, applications and future prospects.
    He L; Zhu Z; Qi C
    Carbohydr Polym; 2024 Sep; 339():122252. PubMed ID: 38823919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yeast-Derived β-Glucan in Cancer: Novel Uses of a Traditional Therapeutic.
    Geller A; Shrestha R; Yan J
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31344853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting tumor-associated macrophages for cancer immunotherapy.
    Shu Y; Cheng P
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188434. PubMed ID: 32956767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of beta-glucans on the immune system.
    Akramiene D; Kondrotas A; Didziapetriene J; Kevelaitis E
    Medicina (Kaunas); 2007; 43(8):597-606. PubMed ID: 17895634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting tumor-associated macrophages as an antitumor strategy.
    Cheng N; Bai X; Shu Y; Ahmad O; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of an innate immune response by soluble yeast β-glucan prepared by a heat degradation method.
    Ishimoto Y; Ishibashi KI; Yamanaka D; Adachi Y; Kanzaki K; Okita K; Iwakura Y; Ohno N
    Int J Biol Macromol; 2017 Nov; 104(Pt A):367-376. PubMed ID: 28602993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mushroom-derived beta-glucan-rich polysaccharide extracts on nitric oxide production by bone marrow-derived macrophages and nuclear factor-kappaB transactivation in Caco-2 reporter cells: can effects be explained by structure?
    Volman JJ; Helsper JP; Wei S; Baars JJ; van Griensven LJ; Sonnenberg AS; Mensink RP; Plat J
    Mol Nutr Food Res; 2010 Feb; 54(2):268-76. PubMed ID: 19885842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting tumor-associated macrophages to synergize tumor immunotherapy.
    Xiang X; Wang J; Lu D; Xu X
    Signal Transduct Target Ther; 2021 Feb; 6(1):75. PubMed ID: 33619259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation of human macrophages and myeloid cells by 2-substituted (1-3)-β-D-glucan from P. parvulus 2.6.
    Notararigo S; de Las Casas-Engel M; de Palencia PF; Corbí AL; López P
    Carbohydr Polym; 2014 Nov; 112():109-13. PubMed ID: 25129723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mushroom β-Glucan May Immunomodulate the Tumor-Associated Macrophages in the Lewis Lung Carcinoma.
    Wang WJ; Wu YS; Chen S; Liu CF; Chen SN
    Biomed Res Int; 2015; 2015():604385. PubMed ID: 26167490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinspired yeast-based β-glucan system for oral drug delivery.
    Wu Y; Li P; Jiang Z; Sun X; He H; Yan P; Xu Y; Liu Y
    Carbohydr Polym; 2023 Nov; 319():121163. PubMed ID: 37567689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucans and applications in drug delivery.
    Lin H; Han R; Wu W
    Carbohydr Polym; 2024 May; 332():121904. PubMed ID: 38431411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor monoclonal antibodies in conjunction with β-glucans: a novel anti-cancer immunotherapy.
    Xiang D; Sharma VR; Freter CE; Yan J
    Curr Med Chem; 2012; 19(25):4298-305. PubMed ID: 22834812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 18. pH-sensitive PEG-coated hyper-branched β-d-glucan derivative as carrier for CpG oligodeoxynucleotide delivery.
    Su Y; Li X; Lam KL; Cheung PCK
    Carbohydr Polym; 2020 Oct; 246():116621. PubMed ID: 32747260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responses.
    Ning Y; Xu D; Zhang X; Bai Y; Ding J; Feng T; Wang S; Xu N; Qian K; Wang Y; Qi C
    Int J Cancer; 2016 Jun; 138(11):2713-23. PubMed ID: 26773960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory effects of beta-glucans on porcine alveolar macrophages and bone marrow haematopoietic cell-derived dendritic cells.
    Chaung HC; Huang TC; Yu JH; Wu ML; Chung WB
    Vet Immunol Immunopathol; 2009 Oct; 131(3-4):147-57. PubMed ID: 19410299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.